ClassID:

170538

G01N2333/8125 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors; Serpins Alpha-1-antitrypsin

Recent Application in this class:
#1
20250383363
2025-12-18

NEUTRALIZATION ANTIBODY ASSAY METHOD

#2
20250305057
2025-10-02

BLADDER CANCER BIOMARKERS AND METHODS OF USE

#3
20250157661
2025-05-15

MONITORING INFLAMMATION STATUS

#4
20250155443
2025-05-15

ALPHA-1 ANTITRYPSIN BIOMARKERS FOR DETECTING AND MONITORING CANCERS

#5
20240175871
2024-05-30

ALPHA-1-ANTITRYPSIN PHENOTYPE C DETECTION AND TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS ASSOCIATED WITH SAID PHENOTYPE

#6
20240158465
2024-05-16

METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS

#7
20240141351
2024-05-02

ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE

#8
20240012010
2024-01-11

METHODS OF MONITORING ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY BY MEASURING POLYMERISED AAT

#9
20230364208
2023-11-16

EFFECTIVE DOSAGE OF RECOMBINANT SERPIN-FC FUSION PROTEIN FOR USE IN A METHOD OF TREATING AAT DEFICIENCY IN A SUBJECT

#10
20230305021
2023-09-28

IMPROVED METHOD AND TEST SYSTEM FOR IN-VITRO DETERMINATION OF DRUG ANTIBODIES IN BLOOD

#11
20230218637
2023-07-13

COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY

#12
20230137242
2023-05-04

METHOD OF SCREENING FOR A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY

#13
20220196663
2022-06-23

Reagents and Methods for Cancer Detection, Prognosis, and Therapeutic Monitoring

#14
20220170015
2022-06-02

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

#15
20220120760
2022-04-21

TREATMENT STRATIFICATION FOR AN EXACERBATION OF INFLAMMATION

#16
20210255192
2021-08-19

METHODS AND KITS FOR DETECTING MISFOLDED PROTEINS

#17
20200208149
2020-07-02

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

#18
20180195069
2018-07-12

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

#19
20180038856
2018-02-08

Compositions and methods for the diagnosis of rheumatoid arthritis

#20
20170356920
2017-12-14

Methods and kits for detecting misfolded proteins

#21
20170242035
2017-08-24

Diagnosis of sepsis and systemic inflammatory response syndrome

#22
20160341746
2016-11-24

QUANTITAQUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS

#23
20160097775
2016-04-07

Methods and kits for detecting misfolded proteins

#24
20160091490
2016-03-31

Compositions and methods for the diagnosis of rheumatoid arthritis

#25
20160011214
2016-01-14

QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS

#26
20150323526
2015-11-12

Immunochromatography devices, methods, and kits

#27
20150265671
2015-09-24

Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin

#28
20150168412
2015-06-18

Methods And Marker Combinations For Screening For Predisposition To Lung Cancer

#29
20150011479
2015-01-08

Alpha1 proteinase inhibitor peptides methods and use

#30
20140349956
2014-11-27

MATERIALS AND METHODS FOR DETECTING AND/OR PREDICTING NECROTIZING ENTEROCOLITIS IN INFANTS

#31
20130288279
2013-10-31

Specific A1AT monoclonal antibodies for detection of endometriosis

#32
20130252906
2013-09-26

Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin

#33
20130252267
2013-09-26

Method of detecting a urine protein fragment and a serum protein fragment

#34
20130183698
2013-07-18

Immunochromatography devices, methods and kits

#35
20120322090
2012-12-20

Solid phase-bound elastase-binding assay for the measurement of alpha-antitrypsin activity

#36
20120289422
2012-11-15

Quantitative diagnostic methods using multiple parameters

#37
20120071334
2012-03-22

Methods And Marker Combinations For Screening For Predisposition To Lung Cancer

#38
20110280863
2011-11-17

Methods and kits for detecting misfolded proteins

#39
20110236913
2011-09-29

Method for diagnosing immunoglobulin A nephropathy and TGBM nephropathy

#40
20110212030
2011-09-01

Nucleic acid ligand complexes

#41
20110086371
2011-04-14

URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY

#42
20110079077
2011-04-07

Urine and serum biomarkers associated with diabetic nephropathy

#43
20100197033
2010-08-05

Urine and serum biomarkers associated with diabetic nephropathy

#44
20100184049
2010-07-22

Glycoprotein Profiling of Bladder Cancer

#45
20100129846
2010-05-27

Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer

#46
20100035284
2010-02-11

Urinary proteomic biomarker patterns in preeclampsia

#47
20100029558
2010-02-04

Alpha1 proteinase inhibitor peptides methods and use

#48
20100004871
2010-01-07

Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer

#49
20090232910
2009-09-17

Biomarkers and therapeutics targets for cognitive decline

#50
20090170071
2009-07-02

SERUM BIOMARKERS OF HEPATITIS B VIRUS INFECTED LIVER AND METHODS FOR DETECTION THEREOF

#51
20090118481
2009-05-07

High Affinity Nucleic Acid Ligands To Lectins

#52
20090035801
2009-02-05

Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer

#53
20080171394
2008-07-17

Method For Diagnosing Multiple Sclerosis

#54
20080160546
2008-07-03

Methods and marker combinations for screening for predisposition to lung cancer

#55
20070087386
2007-04-19

Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers

#56
20070021327
2007-01-25

Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor

#57
20070003943
2007-01-04

Tumor angiogenesis inhibitor alpha 1-antitrypsin

#58
20060204958
2006-09-14

Methods for diagnosing htlv-i-mediated diseases

#59
20060105378
2006-05-18

Tenascin-C nucleic acid ligands

#60
20060088877
2006-04-27

Systematic evolution of ligands by exponential enrichment: Chemi-SELEX

#61
20060084797
2006-04-20

High affinity TGFbeta nucleic acid ligands and inhibitors

#62
20050164974
2005-07-28

Nucleic acid ligand complexes

#63
20050136474
2005-06-23

Truncation SELEX method

#64
20050112560
2005-05-26

Serum biomarkers of hepatitis B virus infected liver and methods for detection thereof

#65
20050043265
2005-02-24

High affinity RNA ligands of basic fibroblast growth factor